N/A
N=111
Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial
Knee Arthroplasty
Bottom Line
View on ClinicalTrials.gov: NCT01003080 ↗Enrolled (actual)
111
Serious AEs
0.0%
Results posted
Apr 2011
Primary outcome: Primary: Drain Output. — 776; 778 mL
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Aquamantys Device (Device); Standard of care treatment for hemostasis during a total knee arthroplasty. (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Montefiore Medical Center
- Primary completion
- Apr 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Drain Output. |
776; 778 | — |
Summary
The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
Eligibility Criteria
Inclusion Criteria
- Patient indicated for total knee arthroplasty
Exclusion Criteria
- Patients undergoing revision total knee arthroplasty
- Patients with blood disorders
- Patients on chronic anti-thrombotic medication such as Coumadin
- Patients with a history of deep vein thrombosis
- Patients with a history of pulmonary embolism
Data sourced from ClinicalTrials.gov (NCT01003080). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.